Literature DB >> 15866476

Function of CD8+ T lymphocytes in a self-curing mouse model of visceral leishmaniasis.

Panagiotis Tsagozis1, Evdokia Karagouni, Eleni Dotsika.   

Abstract

CD8+ T lymphocytes play an important role in the control of visceral leishmaniasis in non self-cure mice (e.g. BALB/c). In the present study, the mode of action of CD8+ T cells and their in vivo contribution to immunity was addressed in self-curing C57BL/6 mice. During the course of the experimental infection, CD8+ T cells specific for Leishmania infantum (L. infantum) developed and apoptotic cell death subsequently followed. They exhibited perforin-dependent cytotoxicity and a T(C)1 profile characterized by secretion of IFN-gamma and CC chemokines. Despite evidence for activation of CD8+ T lymphocytes, both intravenous and intradermal infection of beta2-microglobulin deficient C57BL/6 mice with L. infantum showed that these knockout animals had similar parasite loads to their wild-type counterpart. Lymphocytes from the beta2-microglobulin deficient mice produced high levels of IFN-gamma, reflecting a T(H)1 response to the parasite, which was apparently sufficient for the immunologic control of the pathogen. Thus, despite their functional activation, CD8+ T lymphocytes do not appear to play a primary role in parasite restraint in the self-curing mouse model of visceral leishmaniasis, as shown using beta2-microglobulin deficient mice which do not produce functional CD8+ T lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15866476     DOI: 10.1016/j.parint.2005.02.005

Source DB:  PubMed          Journal:  Parasitol Int        ISSN: 1383-5769            Impact factor:   2.230


  16 in total

1.  CD8 T cell exhaustion in human visceral leishmaniasis.

Authors:  Shalini Gautam; Rajiv Kumar; Neetu Singh; Abhishek Kumar Singh; Madhukar Rai; David Sacks; Shyam Sundar; Susanne Nylén
Journal:  J Infect Dis       Date:  2013-08-06       Impact factor: 5.226

2.  Mechanisms of immune evasion in leishmaniasis.

Authors:  Gaurav Gupta; Steve Oghumu; Abhay R Satoskar
Journal:  Adv Appl Microbiol       Date:  2013       Impact factor: 5.086

3.  Granzyme-mediated regulation of host defense in the liver in experimental Leishmania donovani infection.

Authors:  Henry W Murray; Marisa Mitchell-Flack; Hua Zheng; Xiaojing Ma
Journal:  Infect Immun       Date:  2014-12-01       Impact factor: 3.441

Review 4.  CD8+ T cells in cutaneous leishmaniasis: the good, the bad, and the ugly.

Authors:  Fernanda O Novais; Phillip Scott
Journal:  Semin Immunopathol       Date:  2015-03-24       Impact factor: 9.623

5.  Toxoplasma gondii inhibits granzyme B-mediated apoptosis by the inhibition of granzyme B function in host cells.

Authors:  Tatsuya Yamada; Tadakimi Tomita; Louis M Weiss; Amos Orlofsky
Journal:  Int J Parasitol       Date:  2011-02-15       Impact factor: 3.981

6.  Innate killing of Leishmania donovani by macrophages of the splenic marginal zone requires IRF-7.

Authors:  Rebecca Phillips; Mattias Svensson; Naveed Aziz; Asher Maroof; Najmeeyah Brown; Lynette Beattie; Nathalie Signoret; Paul M Kaye
Journal:  PLoS Pathog       Date:  2010-03-12       Impact factor: 6.823

7.  Adoptive immunotherapy against experimental visceral leishmaniasis with CD8+ T cells requires the presence of cognate antigen.

Authors:  Rosalind Polley; Simona Stager; Sara Prickett; Asher Maroof; Soombul Zubairi; Deborah F Smith; Paul M Kaye
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

8.  Immunogenicity and efficacy of single antigen Gp63, polytope and polytopeHSP70 DNA vaccines against visceral Leishmaniasis in experimental mouse model.

Authors:  Rakhee Sachdeva; Akhil C Banerjea; Nancy Malla; Mohan Lal Dubey
Journal:  PLoS One       Date:  2009-12-02       Impact factor: 3.240

9.  Immunobiology of visceral leishmaniasis.

Authors:  Rajiv Kumar; Susanne Nylén
Journal:  Front Immunol       Date:  2012-08-14       Impact factor: 7.561

Review 10.  Immune evasive mechanisms contributing to persistent Leishmania donovani infection.

Authors:  Simona Stäger; Trupti Joshi; Rashmi Bankoti
Journal:  Immunol Res       Date:  2010-07       Impact factor: 4.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.